Radiotherapy and Rosai-Dorfman disease

 

 Permissions and Reprints All articles of this category

ABSTRACT

Rosai-Dorfman disease (RDD) also known as histiocytosis with lymphadenopathy is an uncommon, often self-limiting benign, non-Langerhans-cell histiocytic proliferative disorder. It usually affects young adults and children, with no predilection by sex. More than 80% of patients present with painless cervical lymphadenopathy, with or without fever. Other presentation sites include upper aero-digestive tract, orbits and the paranasal sinuses. Extra nodal involvement occurs in up to 40% of cases and common sites of involvement include the skin, upper and lower respiratory tract, soft tissue, bones, kidney, liver, orbit and central nervous system. Treatment is not necessary in most instances, but some patients, when symptomatic, may require medical intervention. There is no established guideline for the management of this condition and various therapeutic modalities are used, including surgery, radiotherapy and or chemotherapy.

RESUMO

A doença de Rosai–Dorfman, também conhecida como histiocitose com adenopatia, é uma desordem linfo-proliferativa de histiócitos não Langerhans, rara e geralmente auto limitada. Ela usualmente afeta adultos jovens e crianças, sem predileção por sexo, com ou sem a presença de febre associada. Outros sítios de acometimento incluem o trato aéreo e digestivo altos, orbitas e seios paranasais. O envolvimento extra-nodal pode ocorrer em até 40% e os sítios comumente acometidos são a pele, trato aéreo alto e baixo, partes moles, ossos, rim, fígado, orbita e sistema nervoso central. O tratamento não é necessário na maioria dos casos, porem, em alguns pacientes pode ser necessário algum tipo de in-tervenção. Não existe um protocolo de tratamento estabelecido para essa doença, e são varias as opções terapêuticas que podem ser empregadas, dentre elas cirurgia, radiotera-pia e quimioterapia.

Publication History

Received: 23 June 2017

Accepted: 20 September 2017

Article published online:
25 February 2025

© 2017. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• REFERENCES

• 1 Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopatholo-gical entity. Arch Pathol 1969; 87 (01) 63-70
  PubMedSearch in Google Scholar
• 2 Rosai J, Dorfman RF. Sinus histiocytosis with massive lym-phadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 1972; 30 (05) 1174-88
  PubMedSearch in Google Scholar
• 3 Annessi G, Giannetti A. Purely cutaneous Rosai--Dorfman disease. Br J Dermatol 1996; 134 (04) 749-53
  PubMedSearch in Google Scholar
• 4 Rodriguez-Galindo C, Helton KJ, Sánchez ND, Rieman M, Jeng M, Wang W. Extranodal Rosai-Dorfman disease in children. J Pediatr Hematol Oncol 2004; 26 (01) 19-24
  PubMedSearch in Google Scholar
• 5 Komp DM. The treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Semin Diagn Pathol 1990; 7 (01) 83-6
  PubMedSearch in Google Scholar
• 6 Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease), review of the entity. Semin Diagn Pathol 1990; 7 (01) 19-73
  PubMedSearch in Google Scholar
• 7 Hsiao CH, Tsai TF, Yang TH, Liu CM. Clinicopathologic characteristics of Rosai-Dorfman disease in a medical center in northern taiwan. J Formos Med Assoc 2006; 105 (09) 701-7
  PubMedSearch in Google Scholar
• 8 Thawerani H, Sanchez RL, Rosai J, Dorfman RF. The cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy. Arch Dermatol 1978; 114 (02) 191-7
  PubMedSearch in Google Scholar
• 9 Kong YY, Kong JC, Shi DR, Lu HF, Zhu XZ, Wang J, Chen ZW. Cutaneous rosai-dorfman disease: a clinical and histo-pathologic study of 25 cases in China. Am J Surg Pathol 2007; 31 (03) 341-50
  PubMedSearch in Google Scholar
• 10 Young PM, Kransdorf MJ, Temple HT, Mousavi F, Robinson PG. Rosai-Dorfman disease presenting as multiple soft tissue masses. Skeletal Radiol 2005; 34 (10) 665-9
  PubMedSearch in Google Scholar
• 11 Childs 3rd HA, Kim RY. Radiation response of Rosai-Dorfman disease presenting with involvement of the orbits. Am J Clin Oncol 1999; 22 (05) 526-8
  PubMedSearch in Google Scholar
• 12 Petzold A, Thom M, Powell M, Plant GT. Relapsing intracranial Rosai-Dorfman disease. J Neurol Neurosurg Psychiatry 2001; 71 (04) 538-41
  PubMedSearch in Google Scholar
• 13 Eisen RN, Buckley PJ, Rosai J. Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease). Semin Diagn Pathol 1990; 7 (01) 74-82
  PubMedSearch in Google Scholar
• 14 Palomera L, Domingo JM, Olave T, Romero S, Gutierrez M. Sinus histiocytosis with massive lymphadenopathy: : complete response to low-dose interferon-alpha [letter]. J Clin Oncol 1997; 15 (05) 2176
  PubMedSearch in Google Scholar
• 15 Baildam EM, Ewing CI, D'Souza SW, Stevens RF. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dor-fman disease): response to acyclovir. J R Soc Med 1992; 85 (03) 179-80
  PubMedSearch in Google Scholar